Funded Tech Companies
Agios Pharmaceuticals
Wondering who provided funding to Agios Pharmaceuticals? Celgene, Third Rock Ventures and Arch Venture Partners invested in this innovative biopharmaceutical company.
Company Overview
Company Name
Agios Pharmaceuticals
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
88 Sidney St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Company Background Information
Overview
Agios (NASDAQ: AGIO) is a biopharmaceutical company at the forefront of one of the most exciting new areas of cancer research: cancer metabolism. Cancer metabolism represents a breakthrough understanding of how cancer cells become addicted to using more nutrients than normal cells to ensure their survival and growth.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/24/2013
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jacqualyn Fouse
Chief Financial Officer
Andrew Hirsch
Chief Medical Officer
Chris Bowden
Chief Scientific Officer
Scott Biller
VP - Human Resources
Melissa McLaughlin
VP - Marketing
Darrin Miles
VP - Operations
Clive Patience
Company Investors
- Celgene (Perry Karsen)
- Third Rock Ventures (Kevin Starr)
- Arch Venture Partners (Robert Nelson)
- Flagship Pioneering (Douglas Cole)
- Arch Venture Partners (Robert Nelsen)
Browse more funded tech companies:
Share this article
About Our Venture Capital Transactions Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs